Pfizer, BioNTech coronavirus vaccine candidates get USFDA 'fast track' status Ruchika Sharma15 July 2020 9:30 AM ISTThe two candidates to win the designation, BNT162b1 and BNT162b2, are the most advanced of the at least four vaccines being assessed by the companies...
Pfizer, BioNTech COVID-19 vaccine expected to be ready for approval by 2020 end Ruchika Sharma12 July 2020 9:00 AM ISTIf it receives marketing approval, the companies are preparing to make up to 100 million doses by the end of 2020 and another 1.2 billion doses by the...
Ensure production, adequate stock of methylprednisolone, heparin, dexamethasone: NPPA directs pharma cos Ruchika Sharma10 July 2020 4:49 PM ISTNew Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA) has directed State Drug Controllers (SDCs) to...
Pfizer, BioNTech early trial of COVID-19 vaccine shows promise Ruchika Sharma6 July 2020 9:30 AM ISTNew York: Pfizer Inc. and BioNTech SE have announced preliminary data from the most advanced of four investigational vaccine candidates from their...
Pfizer starts Four Phase 3 Clinical Trials for Investigational Vaccines Ruchika Sharma25 Jun 2020 9:00 AM ISTNew York: Pfizer Inc. has announced the initiation of four Phase 3 clinical trials within its current pipeline of investigational vaccines:Two studies...
Pfizer Abrocitinib hits mark in phase 3 of Atopic Dermatitis trial Ruchika Sharma14 Jun 2020 9:45 AM ISTAbrocitinib received Breakthrough Therapy designation from the FDA for the treatment of patients with moderate to severe AD in February 2018, Pfizer...
